Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome
Margaritis Avgeris, Ioanna Kokkinopoulou, Eirini Maratou, Panagiota Mitrou, Eleni Boutati, Andreas Scorilas, Emmanuel G. Fragoulis, Maria Christodoulou
Topics & Concepts
MedicineType 2 diabetesDiabetes mellitusDiseasemicroRNAMetabolic syndromeBioinformaticsIntensive care medicineInternal medicineGeneticsEndocrinologyGeneBiologyMicroRNA in disease regulationCancer-related molecular mechanisms researchExtracellular vesicles in disease